Jeffrey Allen Bailey

CIK 1500210 · Chief Executive Officer · last filed 2026-06-08

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$23.41M

Companies

9

Total Filings

41

Lifetime Open-Market Net

$40.3K

Filer Profile

Reported Address
BIODELIVERY SCIENCES INTERNATIONAL, INC.
4131 PARKLAKE AVE., SUITE 225
RALEIGH, NC 27612
Related Filers
Lantheus Holdings, Inc. — 5 joint filings, latest 2015-09-03
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
AUPH Director 22,775 $16.10 $366.7K -$38.4K 6 2026-06-08
Rein Therapeutics, Inc. (ALRN) Delisted Director 1,788 $2.11 $3.8K $38.6K 8 2022-06-17
THW Director 980 $13.39 $13.1K $10.1K 2 2021-04-08
THQ Director 570 $18.92 $10.8K $10.1K 1 2020-09-23
HQL Director 580 $19.76 $11.5K $10.0K 1 2020-09-23
HQH Director 490 $21.76 $10.7K $10.0K 1 2020-09-23
LANDAUER INC (LDR) Delisted Director 0 $0 4 2017-10-19
LNTH CEO and President 229,407 $100.25 $23.00M $0 4 2015-09-03
KG Chief Commercial Officer 0 $6.57 $0 $0 2 2011-02-02

Recent Filings · Page 4 of 5

41 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2018-03-19 Rein Therapeutics, Inc. (ALRN) Delisted Grant (A) $0 EDGAR
2017-10-19 LANDAUER INC (LDR) Delisted Disp (D) −8,943 -$601.4K EDGAR
2017-02-21 LANDAUER INC (LDR) Delisted Grant (A) +2,260 $115.0K EDGAR
2016-02-23 LANDAUER INC (LDR) Delisted Grant (A) +3,959 $0 EDGAR
2015-09-03 LNTH Tax (F) −13,020 -$92.8K EDGAR
2015-08-31 LNTH Disp (D) −181,494 $0 EDGAR
2015-07-17 LNTH Grant (A) +40,000 $0 EDGAR
2015-06-25 LNTH Mixed $0 EDGAR
2015-04-17 LANDAUER INC (LDR) Delisted Grant (A) +2,724 $0 EDGAR
2011-02-02 KG Mixed −40,000 $0 EDGAR
Showing 3140 of 41
Page 4 of 5
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.